Table 3.
UCG Measrements | Wild-Type | Nedd4-2 C2 −/− | Wild-Type | Nedd4-2 C2 −/− | p |
---|---|---|---|---|---|
MI | MI | Sham | Sham | ||
(n = 4) | (n = 4) | (n = 4) | (n = 4) | (ANOVA) | |
Week 0 | |||||
IVSTd (mm) | 0.73 ± 0.02 | 0.72 ± 0.02 | 0.72 ± 0.02 | 0.75 ± 0.01 | 0.5464 |
SV (μL) | 44.59 ± 3.69 | 31.67 ± 1.51 a | 45.80 ± 2.38 | 41.88 ± 1.18 | 0.0002 |
CO (mL/min) | 22.81 ± 2.09 | 16.22 ± 0.75 a | 22.40 ± 1.28 | 20.97 ± 0.62 | 0.0017 |
EF (%) | 63.57 ± 1.84 | 67.99 ± 1.17 | 68.25 ± 1.52 | 66.67 ± 1.18 | 0.1427 |
FS (%) | 29.00 ± 1.15 | 31.76 ± 0.81 | 32.16 ± 1.07 | 31.14 ± 0.87 | 0.1860 |
Week 3 | |||||
IVSTd (mm) | 0.70 ± 0.03 | 0.69 ± 0.02 b | 0.76 ± 0.01 | 0.75 ± 0.01 | 0.0327 |
SV (μL) | 57.07 ± 4.85 | 51.09 ± 1.87 | 50.67 ± 4.20 | 49.50 ± 1.77 | 0.3844 |
CO (mL/min) | 27.42 ± 2.26 | 25.29 ± 0.90 | 24.44 ± 0.89 | 24.95 ± 1.12 | 0.3852 |
EF (%) | 69.16 ± 1.23 | 68.81 ± 1.09 | 67.99 ± 3.13 | 68.17 ± 1.14 | 0.9708 |
FS (%) | 32.60 ± 0.86 | 32.44 ± 0.76 | 33.68 ± 0.58 | 32.00 ± 0.80 | 0.4587 |
Week 6 | |||||
IVSTd (mm) | 0.75 ± 0.02 | 0.74 ± 0.02 | 0.77 ± 0.02 | 0.77 ± 0.02 | 0.5427 |
SV (μL) | 58.81 ± 5.38 | 48.68 ± 1.62 | 54.80 ± 2.38 | 58.17 ± 2.69 | 0.1224 |
CO (mL/min) | 29.93 ± 2.86 | 24.33 ± 0.66 | 27.05 ± 1.22 | 28.37 ± 1.39 | 0.1350 |
EF (%) | 69.12 ± 1.11 | 70.45 ± 0.89 | 70.00 ± 0.89 | 69.86 ± 0.99 | 0.8338 |
FS (%) | 32.63 ± 0.77 | 33.39 ± 0.63 | 33.35 ± 0.66 | 33.20 ± 0.73 | 0.8751 |